Serum high density lipoprotein in diabetic patients

Area of Science:

• Biochemistry
• Endocrinology
• Lipid Metabolism

Background:

• Diabetes mellitus is a metabolic disorder characterized by hyperglycemia.
• Lipoprotein abnormalities, particularly in high-density lipoprotein (HDL), are common in diabetes.
• Understanding HDL changes is crucial for managing cardiovascular risk in diabetic patients.

Purpose of the Study:

• To investigate alterations in HDL lipoprotein concentrations in patients with diabetes mellitus.
• To compare HDL-cholesterol and apolipoprotein A levels between diabetic and normal individuals.
• To explore the relationship between HDL parameters and glycemic control in diabetes.

Main Methods:

• Comparative analysis of 40 normal subjects and 109 diabetic patients.
• Quantification of relative HDL concentration using polyacrylamide gel electrophoresis.
• Measurement of HDL-cholesterol and apolipoprotein A concentrations.

Main Results:

• Significant decreases in HDL (18-28%) and HDL-cholesterol (31-40 mg/100 ml) were observed in most diabetic patients.
• Diabetic patients with normalized glucose and lipid levels exhibited higher HDL (34%) and HDL-cholesterol (50 mg/100 ml).
• A negative correlation was found between HDL/HDL-cholesterol and serum glucose levels; apolipoprotein A levels showed no significant difference.

Conclusions:

• Diabetes mellitus is associated with reduced HDL and HDL-cholesterol levels, linked to poorer glycemic control.
• A potential deficiency in cholesterol binding to apolipoprotein A may contribute to these alterations in diabetes.
• Maintaining normalized glucose and lipid levels could mitigate HDL reduction in diabetic individuals.